Targeting PD-L1 decreases fatty acid-binding protein (Fabp) 4 and Fabp5 expression in tumor cells, and the blockade of PD-L1 increases Fabp4/5 expression in Trms, promoting lipid uptake by Trm cells and resulting in better survival (147). Here, GOT2 is linked to neoplasm.